Commentary · 21 Feb 2026
Conference abstractPublished 25 Jul 2019
PET imaging in lymphoma: An update on clinical trails guidelines and clinical practice indications
University of Washington, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
This presentation includes a case-based review illustrating the importance in clinical practice of 18F-FDG -PET images utilization for the initial staging and treatment response assessment in lymphoma patients. A discussion regarding 18F-FDG -avidity for different types of lymphomas and the side effects of the first and second line lymphoma treatments which every nuclear medicine radiologist needs to be familiar with in order to avoid pitfalls in image interpretation is provided. There is included also an overall review of changes presented in the new response evaluation criteria RECIL 2017 as compared to the standard previously published criteria. Learning Objectives include identify differences in Fluorodeoxyglucose (18F-FDG) -avidity based on the histopathologic subtype of lymphoma and becoming familiar with particularities of different types of lymphoma; Summarize the major indications to perform FDG-PET in patients with lymphoma and pearls and pitfalls in image interpretation Discuss criteria for oncologic response assessment. Recent Publications 1. Barrington S F, Mikhaeel N G, Kostakoglu L, Meignan M, Hutchings M, Müeller S P, et al., (2014) Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group. Journal of clinical oncology 32(27):3048-58. 2. Pelosi E, Penna D, Douroukas A, Bello M, Amati A, Arena V, et al., (2011) Bone marrow disease detection with FDG-PET/CT and bone marrow biopsy during the staging of malignant lymphoma: results from a large multicentre study. The quarterly journal of nuclear medicine and molecular imaging 55(4):469-75. 3. Adams H J, Kwee T C, de Keizer B, Fijnheer R, de Klerk J M and Nievelstein R A (2014) FDG PET/CT for the detection of bone marrow involvement in diffuse large B-cell lymphoma: systematic review and meta-analysis. European journal of nuclear medicine and molecular imaging. 41(3):565-74. 4. El-Galaly T C, d'Amore F, Mylam K J, de Nully Brown P, Bogsted M, Bukh A, et al., (2012) Routine bone marrow biopsy has little or no therapeutic consequence for positron emission tomography/computed tomographystaged treatment-naive patients with Hodgkin. J Clin Oncol. 30(36):4508-14.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Cancer Science & Therapy.
Perspective · 21 Feb 2026
Finding Potential Passerini Adducts for Anticancer Drug Development
Perspective · 21 Feb 2026
Head and Neck Cutaneous Squamous Cell Carcinoma with Perineural Invasion
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCancer Science & Therapy
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Manuela Matesan”
